Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6202029

NC(=O)CC1CCCCC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
EPHX1 P07099 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 1/20 0.40
GRM2 Q14416 1/20 0.39
GRM3 Q14832 1/20 0.39
SLC1A3 P43003 3/20 0.38
SLC1A2 P43004 3/20 0.38
SLC1A1 P43005 3/20 0.38
EPHX2 P34913 1/20 0.38
CYP2D6 P10635 1/20 0.37
MLYCD O95822 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2499273 0.90 HSD11B1 (0.40) ALOX5SLC1A3SLC1A2SLC1A1HSD11B1
SCHEMBL1327157 0.85 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL29291470 0.85 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL29291474 0.85 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL24986 0.85 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL20379771 0.85 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
Hydrochloric Acid SCHEMBL6921995 0.83 EPHX1 (0.48) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL8915603 0.83 EPHX1 (0.48) ALOX5EPHX1HPGDKMT2ASLC1A3
Water SCHEMBL28513313 0.83 EPHX1 (0.48) ALOX5EPHX1HPGDKMT2ASLC1A3
Hydrochloric Acid SCHEMBL27773169 0.83 EPHX1 (0.48) ALOX5EPHX1HPGDKMT2ASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377567-B1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GLAXOSMITHKLINE SPA (IT) 2005-12-21 EP claimed